The Valley Desk

ReviewWorld journal of clinical oncologyPublished

Ropeginterferon alfa-2b vs standard therapy in polycythemia vera: A meta-analysis of efficacy and safety outcomes

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Capital Health. Affiliation source

Institution
Capital Health

Publication record

Type
Review
Venue
World journal of clinical oncology
Published
Subject terms
Hydroxyurea; Polycythemia vera; Adverse Events; Molecular Response; Hematologic Response; Ropeginterferon Alfa-2b
PubMed ID
41178922
PubMed Central ID
PMC12576534
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal